Sanara MedTech Inc.
SMTI
$31.64
-$0.08-0.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 21.38% | 7.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 21.38% | 7.50% | |||
| Cost of Revenue | 12.91% | -0.83% | |||
| Gross Profit | 22.24% | 8.43% | |||
| SG&A Expenses | 17.94% | 5.14% | |||
| Depreciation & Amortization | -0.21% | -0.14% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.15% | 5.81% | |||
| Operating Income | -0.34% | 15.61% | |||
| Income Before Tax | 41.01% | 18.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 41.01% | 18.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 540.32% | 0.40% | |||
| Net Income | 46.16% | 18.44% | |||
| EBIT | -0.34% | 15.61% | |||
| EBITDA | -2.75% | 50.43% | |||
| EPS Basic | 46.26% | 18.92% | |||
| Normalized Basic EPS | -6.56% | -2.34% | |||
| EPS Diluted | 46.26% | 18.92% | |||
| Normalized Diluted EPS | -6.56% | -2.34% | |||
| Average Basic Shares Outstanding | 0.17% | 0.57% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||